Sebastien Hazard
Chief Tech/Sci/R&D Officer bei IMUNON, INC.
Vermögen: 32 800 $ am 31.03.2024
Aktive Positionen von Sebastien Hazard
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| IMUNON, INC. | Chief Tech/Sci/R&D Officer | 11.12.2023 | - |
Karriereverlauf von Sebastien Hazard
Ehemalige bekannte Positionen von Sebastien Hazard
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BICYCLE THERAPEUTICS PLC | Corporate Officer/Principal | 01.04.2021 | 01.09.2023 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01.06.2019 | 01.04.2021 |
| TESARO INC | Chief Tech/Sci/R&D Officer | 01.08.2016 | 01.05.2019 |
Ausbildung von Sebastien Hazard
| INSEAD | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 3 |
| Frankreich | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IMUNON, INC. | Health Technology |
| GSK PLC | Health Technology |
| BICYCLE THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Sebastien Hazard
- Erfahrung
